Q32 Bio Inc reports results for the quarter ended in June - Earnings Summary

Q32 Bio

12/08/2024 13:01

* Q32 Bio Inc  QTTB.OQ  reported a quarterly adjusted loss
of
$1.42​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of
$-10.98.  The mean expectation of five analysts for the quarter
was for a loss of $1.04 per share. Wall Street expected
results to range from $-1.18 to -93 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Q32 Bio Inc's reported EPS for the quarter was a loss of
$1.42​.
    * The company reported a quarterly loss of $16.98 million.
    * Q32 Bio Inc shares had risen by 91.8% this quarter and
gained 214.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Q32 Bio Inc is
$57.00 
This summary was machine generated from LSEG data August 12 at
12:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.04          -1.42          Missed
 Mar. 31 2024      -2.32          -14.95         Missed
 Dec. 31 2023      -5.40          -5.04          Beat
 Sep. 30 2023      -7.56          -10.26         Missed